PATENT CLAIM ANALYSIS

Application Number: 16233880
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["435", "006110"]

Abstract:
A screening method for the identification of a characteristic of a target nucleic acid in a whole blood sample, including positioning a composition comprising whole blood and at least one preservative agent within a centrifuge, centrifugating the composition to isolate a plasma that includes at least one target nucleic acid for further analysis and analyzing the at least one target nucleic acid to identify a characteristic about the at least one target nucleic acid, and a composition including the plasma, the preservative agent, and any other ingredient, which is produced by the method.

Claim (Index 7):
The method of  claim 1 , wherein the composition further includes one or more other nonaqueous ingredients selected from the group consisting of glycine, lysine, ethylene diamine, arginine, urea, adenine, guanine, cytosine, thymine, spermidine, ethylenediaminetetraacetic acid (EDTA), aurintricarboxylic acid (ATA), glyceraldehyde, sodium fluoride or combinations thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 2.08333
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14071969', '15937446', '15894077', '12704030', '15601682']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6720707795473254
- 35 USC 102 Novelty (BERT): 0.5032745359879673
- Combined Prediction Score: 0.6551911551913896
- Mean Citation Score: 243.383578
- Max Citation Score: 249.27286
- Similarity Product: 156.53186135706187

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test